Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 5/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 4/20 | 0.33 |
| ▸ | MAOB | P27338 | 4/20 | 0.33 |
| ▸ | ACHE | P22303 | 3/20 | 0.33 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.32 |
| ▸ | TOP2A | P11388 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10153728 | 0.83 | ACHE (0.35) | ELANEMAOAMAOBACHEGRIN1 | |
| SCHEMBL10153477 | 0.74 | MAOA (0.32) | MAOAMAOBACHEATMCYP1A2 | |
| SCHEMBL10153433 | 0.73 | MAOA (0.39) | ALDH1A1MAOAMAOBACHETOP2A | |
| SCHEMBL10153898 | 0.73 | MAOA (0.39) | ALDH1A1MAOAMAOBACHETOP2A | |
| SCHEMBL10153586 | 0.70 | ACHE (0.42) | ELANEMAOAMAOBACHEGRIN1 | |
| SCHEMBL10153562 | 0.70 | MAOA (0.49) | ELANEMAOAMAOBACHEGRIN1 | |
| SCHEMBL10153435 | 0.69 | MAOA (0.46) | ALDH1A1MAOAMAOBACHEGRIN1 | |
| SCHEMBL10153480 | 0.69 | ALKBH5 (0.35) | ATMCYP1A2 | |
| SCHEMBL10153712 | 0.69 | MAOA (0.38) | ELANEMAOAMAOBACHETOP2A | |
| SCHEMBL10153738 | 0.67 | HPGD (0.38) | ALDH1A1CYP2D6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8421066-B2 | Organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2013-04-16 | — | — | US | disclosed |
| US-8421066-B2 | Organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2013-04-16 | — | — | US | disclosed |
| US-20120178928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-8174002-B2 | Organic electroluminescence device | FUJIFILM CORPORATION (JP) | 2012-05-08 | — | — | US | disclosed |
| US-20100051928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100051928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, CHRM1, LEF1 | ELANE 1055/4885ALDH1A1 145/4885MAOA 1485/4885 |
| US-20120178928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, CHRM1, LEF1 | ELANE 1055/4885ALDH1A1 145/4885MAOA 1485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.